Copyright
©The Author(s) 2021.
World J Clin Oncol. Mar 24, 2021; 12(3): 183-194
Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.183
Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.183
Table 3 Comparison of metrics between patients with testicular germ cell tumors at our Institution stratified by those who experienced a thromboembolic event and those who did not
| Thromboembolic event | |||
| Metric | No (%) | Yes (%) | P value |
| n | 49 | 19 | |
| Age [mean (SD)] | 30.9 (7.86) | 30.79 (8.67) | 0.909 |
| BMI [mean (SD)] | 27.87 (6.38) | 30.22 (9.25) | 0.237 |
| Cigarette smoker = Yes (%) | 27 (55.1) | 8 (42.1) | 0.421 |
| Marijuana use = Yes (%) | 13 (26.5) | 3 (15.8) | 0.526 |
| Side of orchiectomy = Right (%) | 27 (55.1) | 6 (31.6) | 0.107 |
| Pathology = Seminoma (%) | 11 (22.4) | 8 (42.1) | 0.135 |
| Pathologic stage (%) | 0.050 | ||
| I | 10 (20.4) | 0 (0.0) | |
| II | 33 (67.3) | 14 (73.7) | |
| III | 6 (12.2) | 5 (26.3) | |
| Port = Yes (%) | 4 (8.2) | 3 (15.8) | 0.390 |
| Type of chemotherapy (%) | |||
| BEP X 3 | 45 (91.8) | 13 (68.4) | |
| BEP X 3 + EP X 1 | 4 (8.2) | 2 (10.5) | |
| EP X 4 | 0 (0.0) | 4 (21.1) | |
| RPLN ≥ 3.0 cm = Yes (%) | 10 (20.4) | 8 (42.1) | 0.123 |
| RPLND = Yes (%) | 12 (24.5) | 6 (31.6) | 0.555 |
| Recurrence after chemotherapy = Yes (%) | 3 (6.1) | 2 (10.5) | 0.614 |
- Citation: Shields LBE, Daniels MW, Mar N, Rezazadeh Kalebasty A. Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy. World J Clin Oncol 2021; 12(3): 183-194
- URL: https://www.wjgnet.com/2218-4333/full/v12/i3/183.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i3.183